Dusquetide Completed Phase 3 Trials for Squamous Cell Carcinoma of the Oral Cavity and Oropharynx / Oral Mucositis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03237325DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer